These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 38136585)
1. Is the β Dwaib HS; Michel MC Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136585 [TBL] [Abstract][Full Text] [Related]
2. Acute β-adrenoceptor mediated glucose clearance in brown adipose tissue; a distinct pathway independent of functional insulin signaling. Olsen JM; Åslund A; Bokhari MH; Hutchinson DS; Bengtsson T Mol Metab; 2019 Dec; 30():240-249. PubMed ID: 31767175 [TBL] [Abstract][Full Text] [Related]
3. Contrasts between the effects of zinc-α2-glycoprotein, a putative β3/2-adrenoceptor agonist and the β3/2-adrenoceptor agonist BRL35135 in C57Bl/6 (ob/ob) mice. Wargent ET; O'Dowd JF; Zaibi MS; Gao D; Bing C; Trayhurn P; Cawthorne MA; Arch JR; Stocker CJ J Endocrinol; 2013 Feb; 216(2):157-68. PubMed ID: 23151357 [TBL] [Abstract][Full Text] [Related]
4. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update. Weyer C; Gautier JF; Danforth E Diabetes Metab; 1999 Mar; 25(1):11-21. PubMed ID: 10335419 [TBL] [Abstract][Full Text] [Related]
5. Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: evidence for a new beta-adrenergic receptor in brown adipose tissue. Preitner F; Muzzin P; Revelli JP; Seydoux J; Galitzky J; Berlan M; Lafontan M; Giacobino JP Br J Pharmacol; 1998 Aug; 124(8):1684-8. PubMed ID: 9756384 [TBL] [Abstract][Full Text] [Related]
6. Glucose uptake of the muscle and adipose tissues in diabetes and obesity disease models: evaluation of insulin and β3-adrenergic receptor agonist effects by Ishino S; Sugita T; Kondo Y; Okai M; Tsuchimori K; Watanabe M; Mori I; Hosoya M; Horiguchi T; Kamiguchi H Ann Nucl Med; 2017 Jun; 31(5):413-423. PubMed ID: 28401400 [TBL] [Abstract][Full Text] [Related]
7. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Ghorbani M; Claus TH; Himms-Hagen J Biochem Pharmacol; 1997 Jul; 54(1):121-31. PubMed ID: 9296358 [TBL] [Abstract][Full Text] [Related]
8. Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise. Santti E; Huupponen R; Rouru J; Hänninen V; Pesonen U; Jhanwar-Uniyal M; Koulu M Br J Pharmacol; 1994 Dec; 113(4):1231-6. PubMed ID: 7889277 [TBL] [Abstract][Full Text] [Related]
9. Lack of responses to a beta3-adrenergic agonist in lipoatrophic A-ZIP/F-1 mice. Gavrilova O; Marcus-Samuels B; Reitman ML Diabetes; 2000 Nov; 49(11):1910-6. PubMed ID: 11078459 [TBL] [Abstract][Full Text] [Related]
10. Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat. Umekawa T; Yoshida T; Sakane N; Saito M; Kumamoto K; Kondo M Eur J Endocrinol; 1997 Apr; 136(4):429-37. PubMed ID: 9150705 [TBL] [Abstract][Full Text] [Related]
11. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat. Malinowska B; Schlicker E Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276 [TBL] [Abstract][Full Text] [Related]
12. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. Tavernier G; Barbe P; Galitzky J; Berlan M; Caput D; Lafontan M; Langin D J Lipid Res; 1996 Jan; 37(1):87-97. PubMed ID: 8820105 [TBL] [Abstract][Full Text] [Related]
13. Effects of ZD7114, a selective beta3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance. Savontaus E; Pesonen U; Rouru J; Huupponen R; Koulu M Eur J Pharmacol; 1998 Apr; 347(2-3):265-74. PubMed ID: 9653893 [TBL] [Abstract][Full Text] [Related]
14. Activation of β3-adrenoceptors increases in vivo free fatty acid uptake and utilization in brown but not white fat depots in high-fat-fed rats. Warner A; Kjellstedt A; Carreras A; Böttcher G; Peng XR; Seale P; Oakes N; Lindén D Am J Physiol Endocrinol Metab; 2016 Dec; 311(6):E901-E910. PubMed ID: 27780820 [TBL] [Abstract][Full Text] [Related]
15. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats. Blachère JC; Pérusse F; Bukowiecki LJ Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483 [TBL] [Abstract][Full Text] [Related]
16. Alpha1- and beta1-adrenoceptor signaling fully compensates for beta3-adrenoceptor deficiency in brown adipocyte norepinephrine-stimulated glucose uptake. Chernogubova E; Hutchinson DS; Nedergaard J; Bengtsson T Endocrinology; 2005 May; 146(5):2271-84. PubMed ID: 15665039 [TBL] [Abstract][Full Text] [Related]
17. Translational Pharmacology and Physiology of Brown Adipose Tissue in Human Disease and Treatment. Larson CJ Handb Exp Pharmacol; 2019; 251():381-424. PubMed ID: 30689089 [TBL] [Abstract][Full Text] [Related]
18. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide. Alemzadeh R; Tushaus KM Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354 [TBL] [Abstract][Full Text] [Related]
19. Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents. Arch JR; Ainsworth AT; Ellis RD; Piercy V; Thody VE; Thurlby PL; Wilson C; Wilson S; Young P Int J Obes; 1984; 8 Suppl 1():1-11. PubMed ID: 6152555 [TBL] [Abstract][Full Text] [Related]